These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 4840489)
1. [Experimental clinical study of the effectiveness of glycopeptide in gastroduodenal pathology]. Vera Camba M; Villalgordo Aparicio C; Güemes Díaz F; Arias Vallejo E Rev Esp Enferm Apar Dig; 1974 Mar; 43(2):225-34. PubMed ID: 4840489 [No Abstract] [Full Text] [Related]
2. [Proglumide in peptic ulcer and in gastroduodenal pathology. Clinical, biological and endoscopic study]. Bennani A Med Chir Dig; 1979; 8(4):351-6. PubMed ID: 502629 [No Abstract] [Full Text] [Related]
3. [Clinical evaluation of an antiulcer glycopeptide sulfate]. Consiglio G; Danieli G; Lazzarini A; Soregaroli V Minerva Gastroenterol; 1972; 18(2):91-6. PubMed ID: 4614113 [No Abstract] [Full Text] [Related]
4. [Clinical experimentation with a new antiulcer drug: glycopeptide sulfate]. Magaraci G Minerva Gastroenterol; 1972; 18(2):86-90. PubMed ID: 4614112 [No Abstract] [Full Text] [Related]
5. [Endoscopic evaluation of the treatment of peptic ulcer with glycopeptide sulfate (granular peptide)]. Meloni M Minerva Dietol Gastroenterol; 1978; 24(4):325-30. PubMed ID: 757275 [No Abstract] [Full Text] [Related]
6. [A new drug, the hydrochloride of the beta-dimethylaminoethylic ester of alpha, alpha-diphenyl-alpha-propargoxyacetic acid in therapy of gastroduodenal disorders]. Barlattani M; Carignola W Clin Ter; 1970 Feb; 52(4):343-60. PubMed ID: 5527879 [No Abstract] [Full Text] [Related]
7. [Therapeutic prospects with a sulfoglycopeptide (sulglycotide) in gastroduodenal ulcer]. Ruffa S; Ghirlanda G; Fedeli G; Greco AV Clin Ter; 1974 Mar; 68(5):469-76. PubMed ID: 4365164 [No Abstract] [Full Text] [Related]
8. [Clinical evaluation of a new synthetic preparation (zolimidine) in the treatment of gastroduodenal diseases]. Rivero Fontán JL; Barranco Jiménez M; Gómez Parra M Rev Esp Enferm Apar Dig; 1972 Jul; 38(1):103-26. PubMed ID: 5069487 [No Abstract] [Full Text] [Related]
9. [Problems of gastrointestinal therapy in pregnancy]. Piccione E Clin Ter; 1987 Jul; 122(1):55-9. PubMed ID: 2973897 [No Abstract] [Full Text] [Related]
10. [Clinical experiences with a new drug with antiulcerous action: glycopeptide sulfate]. Michetti P; De Conca V; Giunta P Clin Ter; 1972 Oct; 63(1):61-9. PubMed ID: 4566105 [No Abstract] [Full Text] [Related]
11. [Combined antigastrin therapy in gastroduodenal diseases with CR 242 B (proglumide-buscapine)]. La Banda Sañchez F Rev Esp Enferm Apar Dig; 1972 Jan; 36(2):231-40. PubMed ID: 5009968 [No Abstract] [Full Text] [Related]
12. Trithiozine: a new agent for peptic ulcer and hypersecretory disorders. Pellegrini R; Albrici A Farmaco Prat; 1979 Mar; 34(3):138-40. PubMed ID: 456549 [No Abstract] [Full Text] [Related]
13. [Content in the gastric juice of sialic acid, hexosamine and hexoses bound with proteins in peptic ulcer patients]. RABINOVICH PD Vopr Med Khim; 1962; 8():500-4. PubMed ID: 13972862 [No Abstract] [Full Text] [Related]
14. [Trial of a new drug in the treatment of gastroduodenal ulcer and gastrointestinal disorders]. Bogazzi G; Fusco E Minerva Gastroenterol; 1968; 14(4):258-64. PubMed ID: 5745806 [No Abstract] [Full Text] [Related]
15. One-week once-daily triple therapy for Helicobacter pylori--a pilot study. Chu KM; Kwok KF; Law SY; Wong J Hepatogastroenterology; 2000; 47(36):1624-6. PubMed ID: 11149018 [TBL] [Abstract][Full Text] [Related]